SCHEDULE 13G RE BIOCRYST PHARMACEUTICALS, INC. 02-12-2007

Company

BIOCRYST PHARMACEUTICALS INC

Filed

February 13, 2007

Accession Number

0000906344-07-000168

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →